Mesoblast Ltd (MESO)
11.32
-0.38
(-3.25%)
USD |
NASDAQ |
Nov 14, 16:00
10.50
-0.82
(-7.24%)
After-Hours: 20:00
Mesoblast Shareholders Equity (Quarterly): 501.84M for June 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 480.36M |
December 31, 2023 | 508.73M |
June 30, 2023 | 501.84M |
March 31, 2023 | 482.17M |
December 31, 2022 | 500.00M |
September 30, 2022 | 522.81M |
June 30, 2022 | 497.04M |
March 31, 2022 | 517.13M |
December 31, 2021 | 535.51M |
September 30, 2021 | 559.75M |
June 30, 2021 | 581.40M |
March 31, 2021 | 600.93M |
December 31, 2020 | 518.73M |
September 30, 2020 | 538.51M |
June 30, 2020 | 549.33M |
March 31, 2020 | 487.81M |
December 31, 2019 | 500.80M |
September 30, 2019 | 475.15M |
June 30, 2019 | 481.05M |
March 31, 2019 | 500.94M |
December 31, 2018 | 524.56M |
Date | Value |
---|---|
September 30, 2018 | 527.60M |
June 30, 2018 | 546.01M |
March 31, 2018 | 556.14M |
December 31, 2017 | 575.60M |
September 30, 2017 | 559.59M |
June 30, 2017 | 516.77M |
March 31, 2017 | 540.40M |
December 31, 2016 | 510.52M |
September 30, 2016 | 509.87M |
June 30, 2016 | 528.16M |
March 31, 2016 | 478.94M |
December 31, 2015 | 492.75M |
June 30, 2015 | 467.99M |
December 31, 2014 | 584.87M |
June 30, 2014 | 571.72M |
December 31, 2013 | 637.76M |
December 31, 2013 | 637.76M |
June 30, 2013 | 630.27M |
December 31, 2012 | 453.52M |
June 30, 2012 | 478.85M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
480.36M
Minimum
Jun 2024
600.93M
Maximum
Mar 2021
522.52M
Average
517.13M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
Alterity Therapeutics Ltd | 26.42M |
Kazia Therapeutics Ltd | 3.589M |
Immutep Ltd | 22.88M |
Opthea Ltd | -75.81M |
Immuron Ltd | 8.495M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 669.42M |
Total Liabilities (Quarterly) | 167.58M |